Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Factors Affecting Drug Distribution: Organ Perfusion Rate

Factors Affecting Drug Distribution: Organ Perfusion Rate

Drug distribution within the body is a complex process influenced by several factors, including perfusion rate, the rate at which the bloodstream transports drugs to tissue. This limitation becomes particularly significant when dealing with highly lipophilic drugs. In such cases, the rate at which the drug can move across membranes is crucial, and if the membrane is highly permeable to the drug, distribution becomes rate-limited by perfusion.
Perfusion rate-limited distribution relies on the...

Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models

Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models

Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...

Pharmacokinetic–Pharmacodynamic Relationship: Problems

Pharmacokinetic–Pharmacodynamic Relationship: Problems

The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...

Model Approaches for Pharmacokinetic Data: Physiological Models

Model Approaches for Pharmacokinetic Data: Physiological Models

Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...

Pharmacokinetic Models: Comparison and Selection Criterion

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Topical hydrosulphide ion gels: A Paradigm shift in onychomycosis treatment.

Acta biomaterialia·2026

Same author

Correction: Hearts deficient in both Mfn1 and Mfn2 are protected against acute myocardial infarction.

Cell death & disease·2021

Same author

The two-sided role of the vaginal microbiome in Chlamydia trachomatis and Mycoplasma genitalium pathogenesis.

Journal of reproductive immunology·2018

Same author

Protection of cerebral microcirculation, mitochondrial function, and electrocortical activity by small-volume resuscitation with terlipressin in a rat model of haemorrhagic shock.

British journal of anaesthesia·2018

Same author

The anion study: effect of different crystalloid solutions on acid base balance, physiology, and survival in a rodent model of acute isovolaemic haemodilution.

British journal of anaesthesia·2018

Same author

An ionization pressure gauge with LaB<sub>6</sub> emitter for long-term operation in strong magnetic fields.

The Review of scientific instruments·2018

Search research articles

Related Experiment Video

Updated: Jun 23, 2026

Modified Langendorff Perfusion for Extended Perfusion Times of Rodent Cardiac Grafts

Modified Langendorff Perfusion for Extended Perfusion Times of Rodent Cardiac Grafts

Published on: June 14, 2024

Pharmacological optimization of tissue perfusion.

N Mongardon¹, A Dyson, M Singer

¹Bloomsbury Institute of Intensive Care Medicine, Wolfson Institute for Biomedical Research and Department of Medicine, University College London, London, UK.

British Journal of Anaesthesia

|May 23, 2009

Summary

Vasoactive drug treatment is crucial for circulatory support after fluid resuscitation. This review discusses optimal agent selection, dosing, timing, and monitoring to maximize patient benefit while minimizing harm.

More Related Videos

An Open-Source Normothermic Perfusion System Designed for Research Scientists

An Open-Source Normothermic Perfusion System Designed for Research Scientists

Published on: July 18, 2025

Related Experiment Videos

Last Updated: Jun 23, 2026

Modified Langendorff Perfusion for Extended Perfusion Times of Rodent Cardiac Grafts

Modified Langendorff Perfusion for Extended Perfusion Times of Rodent Cardiac Grafts

Published on: June 14, 2024

An Open-Source Normothermic Perfusion System Designed for Research Scientists

An Open-Source Normothermic Perfusion System Designed for Research Scientists

Published on: July 18, 2025

Area of Science:

Critical care medicine
Pharmacology

Background:

Vasoactive drug therapy is essential for managing circulatory dysfunction following fluid resuscitation.
Optimal strategies for vasoactive agent use remain a subject of ongoing clinical debate.

Purpose of the Study:

To review current knowledge on vasoactive drug treatment in critical care.
To highlight key areas of debate including agent choice, dosing, timing, targets, and monitoring.
To introduce novel pharmacological agents that expand therapeutic options.

Main Methods:

Literature review focusing on vasoactive drug therapy in circulatory impairment.
Analysis of current clinical practices and emerging research.

Main Results:

Identified critical areas of ongoing debate in vasoactive drug management.
Presented new pharmacological agents that offer broader therapeutic possibilities.

Conclusions:

Optimizing vasoactive drug therapy requires careful consideration of multiple factors to balance efficacy and safety.
Emerging pharmacological options may improve patient outcomes in circulatory dysfunction.